Stock data
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB) reported revenue of US$0.79M and net income of US$5.70M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.79M | — | -US$93.97M | US$5.70M | — |
| 2024 | US$0.00M | — | -US$121.31M | US$0.14M | — |
| 2023 | US$0.00M | — | -US$195.10M | -US$113.72M | — |
| 2022 | US$7.13M | — | -US$179.91M | -US$250.16M | — |
| 2021 | US$143.86M | — | -US$64.49M | -US$65.58M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.74M | US$4.58M | — |
| 2026-03-31 | US$0.36M | -US$19.91M | — |
| 2025-12-31 | US$0.44M | -US$15.34M | — |
| 2025-09-30 | US$0.35M | US$8.20M | — |
| 2025-06-30 | US$0.00M | -US$19.86M | — |
| 2025-03-31 | US$0.00M | US$32.68M | — |
| 2024-12-31 | US$0.00M | -US$15.64M | — |
| 2024-09-30 | US$0.00M | US$88.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.